According to recent reports, health officials are expected to decide on a new COVID-19 design by early July to potentially spike COVID-19 this fall and winter.
Peter Marks, FDA’s director of vaccines, said a formal decision on the new vaccine design is expected to be made after the FDA’s advisory committee meets on June 28 to review the data. data from vaccine companies about new vaccine versions currently being tested. From there, the FDA will decide which vaccine companies should proceed, which is estimated based on what could be used to best protect against new COVID-19 variants this fall and winter.
In a statement about the FDA’s plans, Dr. Marks said, “We’re going to have to make some decisions in early July to make sure the manufacturers know what we’re doing, so they know what we’re doing. what they have to start producing in bulk.” He also stressed that another virus outbreak is expected during the colder months of this year.
Among the additional topics being considered involve an updated way to give people “the longest period of high level of protection” with a new vaccine — mainly because it is expected that It is impractical for people to continue to get a COVID-19 vaccine every few months.
Meanwhile, health officials are also closely monitoring the current COVID-19 surge, as cases are steadily increasing with nearly a third of the U.S. located in intermediate or high-risk communities. for viruses.
Want updates directly in your inbox? Contact us at 917-722-8057 or click here to join!
